Search | IOVS | ARVO Journals

Showing 1 – 20 of 36

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Special Issue April 2021

IMI Impact of Myopia

PDF

Padmaja Sankaridurg; Nina Tahhan; Himal Kandel; Thomas Naduvilath; Haidong Zou; Kevin D. Frick; Srinivas Marmamula; David S. Friedman; Ecosse Lamoureux; Jill Keeffe; Jeffrey J. Walline; Timothy R. Fricke; Vilas Kovai; Serge Resnikoff
TAGS: myopia
Invest. Ophthalmol. Vis. Sci.. 2021; 62(5):2. https://doi.org/10.1167/iovs.62.5.2

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

Psychosocial Assessment of Potential Retinal Prosthesis Recipients

Lauren N Ayton; Fleur O'Hare; Gregory C Murphy; Robert Patrick Finger; Chi D Luu; Jill Keeffe; Carla J Abbott; Robyn H Guymer; Sharon A Bentley

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3888.

ARVO Annual Meeting Abstract June 2017

Global Prevalence of Blindness and Distance and Near Vision Impairment: Magnitude, Temporal Trends, and Projections

Rupert R A Bourne; Seth Flaxman; Tasanee Braithwaite; Jost B Jonas; Jill Keeffe; John H Kempen; Janet L Leasher; Hans Limburg; Kovin Shunmugam Naidoo; Konrad Pesudovs; Serge Resnikoff; Gretchen Stevens; Nina Tahhan; Tien Wong; Hugh Taylor

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):840.

ARVO Annual Meeting Abstract June 2017

Contextual factors that impact on the life of children with vision impairment

Jill E Keeffe; Vijaya Gothwal; Serge Resnikoff; Deepak Bagga

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1353.

ARVO Annual Meeting Abstract June 2017

Estimated Prevalence of Visual Impairment in Sub-Saharan Africa (2015)

John H Kempen; Rupert R A Bourne; Tien Yin Wong; Hugh Taylor; Nina Tahhan; Gretchen Stevens; Serge Resnikoff; Konrad Pesudovs; Hans Limburg; Janet L Leasher; Jill E Keeffe; Jost B Jonas; Tasanee Braithwaite; Seth Flaxman; Kovin Shunmugam Naidoo

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2197.

Low Vision October 2015

Number of People Blind or Visually Impaired by Cataract Worldwide and in World Regions, 1990 to 2010

PDF

Moncef Khairallah; Rim Kahloun; Rupert Bourne; Hans Limburg; Seth R. Flaxman; Jost B. Jonas; Jill Keeffe; Janet Leasher; Kovin Naidoo; Konrad Pesudovs; Holly Price; Richard A. White; Tien Y. Wong; Serge Resnikoff; Hugh R. Taylor; for the Vision Loss Expert Group of the Global Burden of Disease Study
TAGS: blindness, cataract, prevalence
Invest. Ophthalmol. Vis. Sci.. 2015; 56(11):6762-6769. https://doi.org/10.1167/iovs.15-17201

ARVO Annual Meeting Abstract June 2015

Task Sharing in the Eye Care Workforce for Detection and Management of Diabetic Retinopathy in Low Resource Countries

MUFARRIQ SHAH; Rahul Chakrabarti; Ayesha Noor; Gail Ormsby; Jing Xie; Alex Harper; Jill Keeffe

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1373.

Low Vision April 2015

The Influence of Coping on Vision-Related Quality of Life in Patients With Low Vision: A Prospective Longitudinal Study

PDF

Bonnie A. Sturrock; Jing Xie; Edith E. Holloway; Ecosse L. Lamoureux; Jill E. Keeffe; Eva K. Fenwick; Gwyneth Rees
TAGS: coping behavior, prospective studies, quality of life, vision, visual impairment
Invest. Ophthalmol. Vis. Sci.. 2015; 56(4):2416-2422. https://doi.org/10.1167/iovs.14-16223

Includes: Supplemental Content

Low Vision October 2014

Developing the Impact of Vision Impairment–Very Low Vision (IVI-VLV) Questionnaire as Part of the LoVADA Protocol

PDF

Robert P. Finger; Betty Tellis; Julie Crewe; Jill E. Keeffe; Lauren N. Ayton; Robyn H. Guymer
TAGS: questionnaires, visual impairment, blindness
Invest. Ophthalmol. Vis. Sci.. 2014; 55(10):6150-6158. https://doi.org/10.1167/iovs.14-14731

Includes: Supplemental Content

ARVO Annual Meeting Abstract April 2014

Number of People Blind or Visually Impaired or by Glaucoma Worldwide and in World Regions 1990 - 2010

Rupert Bourne; Jost B Jonas; Seth R Flaxman; Jill Keeffe; Janet Leasher; Kovin Shunmugam Naidoo; Konrad Pesudovs; Tien Y Wong; Serge Resnikoff; Hugh R Taylor; The Vision Loss Expert Group of the Global Burden of Disease Study

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4278.

ARVO Annual Meeting Abstract April 2014

Number of People Blind or Visually Impaired by Diabetic Retinopathy Worldwide and in World Regions 1990 - 2010

Janet L Leasher; Jost B Jonas; Rupert Bourne; Seth R Flaxman; Jill Keeffe; Kovin Shunmugam Naidoo; Konrad Pesudovs; Tien Y Wong; Serge Resnikoff; Hugh R Taylor; Vision Loss Expert Group of the Global Burden of Disease Study 2010

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5366.

ARVO Annual Meeting Abstract April 2014

Vision Impairment and Blindness due to Age-Related and other Macular Degenerations Globally: A Systematic Review and Meta-Analysis

Jill Keeffe; Jost B Jonas; Rupert Bourne; Tien Y Wong; Janet L Leasher; Kovin Shunmugam Naidoo; Holly Price; Seth R Flaxman; Serge Resnikoff; Hugh R Taylor; Global Burden of Disease Vision Loss Expert Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6083.

ARVO Annual Meeting Abstract April 2014

Prevalence and causes of vision loss in Sub-Saharan Africa: 1990-2010.

Kovin Shunmugam Naidoo; Stephen Gichuhi; María-Gloria Basáñez; Seth R Flaxman; Jost B Jonas; Jill Keeffe; Janet L Leasher; Konrad Pesudovs; Holly Price; Jennifer L Smith; Vision Loss Expert Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6085.

ARVO Annual Meeting Abstract April 2014

A model of 10-year outcomes of anti-VEGF treatment for neovascular age-related macular degeneration

Robert Patrick Finger; Jing Xie; Ya-seng Hsueh; Jill Keeffe; Robyn H Guymer

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3957.

ARVO Annual Meeting Abstract April 2014

Prevalence and Causes of Vision Loss in North Africa and the Middle East: 1990-2010.

Moncef Khairallah; Rim Kahloun; Jost B Jonas; Jill Keeffe; Kovin Shunmugam Naidoo; Serge Resnikoff; Hugh R Taylor; Rupert Bourne; Vision Loss Expert Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4159.

Low Vision November 2013

Identifying Distinct Risk Factors for Vision-Specific Distress and Depressive Symptoms in People With Vision Impairment

PDF

Gwyneth Rees; Jing Xie; Edith E. Holloway; Bonnie A. Sturrock; Eva K. Fenwick; Jill E. Keeffe; Ecosse Lamoureux
TAGS: depressive disorders, risk factors, vision, visual impairment, coping behavior
Invest. Ophthalmol. Vis. Sci.. 2013; 54(12):7431-7438. https://doi.org/10.1167/iovs.13-12153

ARVO Annual Meeting Abstract June 2013

Modeling the Risks of Age-related Macular Degeneration and its Predictive Comparisons in a Population in South India

Krishnaiah Sannapaneni; Bapi Rajiu Surampudi; Jill Keeffe

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):235.

ARVO Annual Meeting Abstract June 2013

Optimizing cost-effectiveness analyses of treatments for neovascular age-related macular degeneration using real-life data

Robert Finger; Arthur Hsueh; Jill Keeffe; Robyn Guymer

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4388.

Low Vision February 2013

Evaluation of a Vision-Related Utility Instrument: The German Vision and Quality of Life Index

PDF

Robert P. Finger; Karsten Kortuem; Eva Fenwick; Bettina von Livonius; Jill E. Keeffe; Christoph W. Hirneiss
TAGS: german, quality of life, vision, visual impairment, rasch model, psychometrics
Invest. Ophthalmol. Vis. Sci.. 2013; 54(2):1289-1294. https://doi.org/10.1167/iovs.12-10828

ARVO Annual Meeting Abstract March 2012

The Impact Of Anti-vegf Treatment On Vision-related Quality Of Life In Age-related Macular Degeneration Outside Clinical Trials

Robert P. Finger; Jennifer B. Hassell; Farshad Abedi; Mark C. Gillies; Jill E. Keeffe; Robyn H. Guymer

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6521.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

IMI Impact of Myopia

Psychosocial Assessment of Potential Retinal Prosthesis Recipients

Global Prevalence of Blindness and Distance and Near Vision Impairment: Magnitude, Temporal Trends, and Projections

Contextual factors that impact on the life of children with vision impairment

Estimated Prevalence of Visual Impairment in Sub-Saharan Africa (2015)

Number of People Blind or Visually Impaired by Cataract Worldwide and in World Regions, 1990 to 2010

Task Sharing in the Eye Care Workforce for Detection and Management of Diabetic Retinopathy in Low Resource Countries

The Influence of Coping on Vision-Related Quality of Life in Patients With Low Vision: A Prospective Longitudinal Study

Developing the Impact of Vision Impairment–Very Low Vision (IVI-VLV) Questionnaire as Part of the LoVADA Protocol

Number of People Blind or Visually Impaired or by Glaucoma Worldwide and in World Regions 1990 - 2010

Number of People Blind or Visually Impaired by Diabetic Retinopathy Worldwide and in World Regions 1990 - 2010

Vision Impairment and Blindness due to Age-Related and other Macular Degenerations Globally: A Systematic Review and Meta-Analysis

Prevalence and causes of vision loss in Sub-Saharan Africa: 1990-2010.

A model of 10-year outcomes of anti-VEGF treatment for neovascular age-related macular degeneration

Prevalence and Causes of Vision Loss in North Africa and the Middle East: 1990-2010.

Identifying Distinct Risk Factors for Vision-Specific Distress and Depressive Symptoms in People With Vision Impairment

Modeling the Risks of Age-related Macular Degeneration and its Predictive Comparisons in a Population in South India

Optimizing cost-effectiveness analyses of treatments for neovascular age-related macular degeneration using real-life data

Evaluation of a Vision-Related Utility Instrument: The German Vision and Quality of Life Index

The Impact Of Anti-vegf Treatment On Vision-related Quality Of Life In Age-related Macular Degeneration Outside Clinical Trials

To View More...

You must be signed into an individual account to use this feature.